Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.805 USD | +4.20% |
|
+12.59% | +12.88% |
08/07 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
01/07 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.88% | 198M | |
+25.39% | 46.56B | |
+45.38% | 41.67B | |
+0.37% | 41.16B | |
+33.38% | 32.4B | |
+21.02% | 28.18B | |
-6.35% | 28.1B | |
+49.10% | 14.52B | |
+47.53% | 13.74B | |
+3.36% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Insider Buy: Outlook Therapeutics